• Layoff Tracker: Novartis cuts New Jersey workforce again, ousting 322 employees BioSpace Wed, 08 Jul 2026 07:00:00 GMT
• Retargeted Serine Integrases Enable Precise Large-Gene Insertion CRISPR Medicine News Mon, 06 Jul 2026 12:31:30 GMT
• Sangamo Therapeutics Q1 2026 Earnings: Significant EPS Miss as Development Continues - Earnings Season Outlook dars.gov.et Mon, 06 Jul 2026 05:48:07 GMT
• Database of Publicly Announced U.S. FDA RMAT Designations, 2026 BioInformant Fri, 03 Jul 2026 07:00:00 GMT
• Sangamo Shares Shift to OTC Market Amid Bankruptcy The Globe and Mail Thu, 02 Jul 2026 21:06:00 GMT
• sangamo therapeutics(sgmoq) stock options chain | quotes & news Moomoo Wed, 01 Jul 2026 13:11:13 GMT
• Sangamo Therapeutics (SGMOQ) Pe Ratio (TTM) Zacks Investment Research Wed, 01 Jul 2026 07:00:00 GMT
• layoff tracker: biocryst ends all internal discovery efforts BioSpace Tue, 30 Jun 2026 07:00:00 GMT
• sangamo therapeutics(sgmo) stock options chain | quotes & news Moomoo Tue, 30 Jun 2026 01:47:20 GMT
• database of publicly announced u.s. fda rmat designations, 2026 BioInformant Sun, 28 Jun 2026 07:00:00 GMT
• sgmoq: sangamo therapeutics - price & eps surprise Zacks Investment Research Fri, 26 Jun 2026 21:21:04 GMT
• SGMOQ: Sangamo Therapeutics - Full Company Report Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• What is the current Price Target and Forecast for Sangamo Therapeutics (SGMOQ) Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• SGMOQ : Sangamo Therapeutics Key Company Details Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• Sangamo Therapeutics (SGMOQ) Revenue (Quarterly) Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• Sangamo Therapeutics (SGMOQ) Total Expenses (TTM) Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• Sangamo Therapeutics (SGMOQ) Cash From Financing (TTM) Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• sangamo therapeutics (sgmoq) gross profit (ttm) Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• sangamo therapeutics (sgmoq) cash from operations (quarterly) Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• sangamo therapeutics (sgmoq) revenue (ttm) Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• sangamo therapeutics (sgmoq) revenue (quarterly) yoy growth Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• sangamo therapeutics (sgmoq) net income (ttm) Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• sangamo therapeutics (sgmoq) earnings yield (ttm) Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• what date does sangamo therapeutics's (sgmoq) report earnings - earnings calendar & announcement Zacks Investment Research Fri, 26 Jun 2026 19:58:00 GMT
• rx rundown: merck kgaa, abbvie, sangamo therapeutics and more Medical Marketing and Media Fri, 26 Jun 2026 11:01:36 GMT
• long term debt to total equity ratio of sangamo therapeutics, inc. – otc:sgmoq TradingView Fri, 26 Jun 2026 08:26:06 GMT
• ebitda margin % of sangamo therapeutics, inc. – otc:sgmoq TradingView Fri, 26 Jun 2026 08:25:57 GMT
• sgmoq: sangamo therapeutics - comparison to industry Zacks Investment Research Fri, 26 Jun 2026 05:46:34 GMT
• SGMOQ: Sangamo Therapeutics - Insider Transations Zacks Investment Research Fri, 26 Jun 2026 05:46:33 GMT
• SGMOQ: Sangamo Therapeutics - 12 Month EPS Zacks Investment Research Fri, 26 Jun 2026 05:46:31 GMT
• sangamo therapeutics (sgmoq) pe ratio (ttm) Zacks Investment Research Fri, 26 Jun 2026 05:46:30 GMT
• SGMOQ: Sangamo Therapeutics - Price & Consenus Chart Zacks Investment Research Thu, 25 Jun 2026 19:58:00 GMT
• sgmoq: sangamo therapeutics - brokerage recommendations chart Zacks Investment Research Thu, 25 Jun 2026 19:58:00 GMT
• sangamo therapeutics (sgmoq) pe ratio (ttm) Zacks Investment Research Thu, 25 Jun 2026 19:58:00 GMT
• sgmoq: sangamo therapeutics - full company report Zacks Investment Research Thu, 25 Jun 2026 19:58:00 GMT
• what is the current price target and forecast for sangamo therapeutics (sgmoq) Zacks Investment Research Thu, 25 Jun 2026 19:58:00 GMT
• sgmoq: sangamo therapeutics - interactive chart Zacks Investment Research Thu, 25 Jun 2026 19:58:00 GMT
• what date does sangamo therapeutics's (sgmoq) report earnings - earnings calendar & announcement Zacks Investment Research Thu, 25 Jun 2026 19:58:00 GMT
• sangamo therapeutics, inc. actuals & estimates (otc:sgmoq) TradingView Thu, 25 Jun 2026 17:22:32 GMT
• price to earnings ratio of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 14:30:29 GMT
• price to sales ratio of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 14:12:09 GMT
• operating cash flow per share of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 14:03:32 GMT
• diluted earnings per share (diluted eps) of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 13:43:57 GMT
• Sangamo Therapeutics, Inc. Financial Disclosures & SEC Filings TradingView Thu, 25 Jun 2026 13:33:33 GMT
• enterprise value to ebitda ratio of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 08:54:10 GMT
• return on equity % of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 08:52:26 GMT
• long term debt to total assets ratio of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 08:50:21 GMT
• price to book forward of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 08:48:28 GMT
• price to cash flow ratio of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 08:44:46 GMT
• ebitda per share of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 08:43:22 GMT
• price to sales forward of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 08:34:37 GMT
• total liabilities of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 05:30:42 GMT
• cash flow from operating activities of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 05:30:37 GMT
• net current asset value per share of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 03:52:37 GMT
• sangamo therapeutics, inc. revenue breakdown – otc:sgmoq TradingView Thu, 25 Jun 2026 03:44:54 GMT
• cash flow from investing activities of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 03:14:59 GMT
• total common shares outstanding of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 03:09:58 GMT
• operating margin % of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 03:09:27 GMT
• discontinued operations of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 03:08:39 GMT
• price to earnings forward of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 02:39:36 GMT
• after tax other income/expense of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 02:22:15 GMT
• enterprise value of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:56:08 GMT
• total debt per share of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:54:45 GMT
• return on invested capital % of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:53:13 GMT
• gross margin % of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:51:56 GMT
• debt to equity ratio of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:51:11 GMT
• return on assets % of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:48:04 GMT
• Preferred dividends of Sangamo Therapeutics, Inc. – OTC:SGMOQ TradingView Thu, 25 Jun 2026 01:45:05 GMT
• diluted shares outstanding of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:43:29 GMT
• Non-controlling/minority interest of Sangamo Therapeutics, Inc. – OTC:SGMOQ TradingView Thu, 25 Jun 2026 01:43:06 GMT
• sangamo therapeutics, inc. earnings and revenue – otc:sgmoq TradingView Thu, 25 Jun 2026 01:17:47 GMT
• net income before discontinued operations of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:13:03 GMT
• price to book ratio of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:09:56 GMT
• equity in earnings of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:07:21 GMT
• basic earnings per share (basic eps) of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:06:46 GMT
• cost of goods sold of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:06:45 GMT
• dilution adjustment of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:03:34 GMT
• Sangamo Therapeutics, Inc. Financial Statements – OTC:SGMOQ TradingView Thu, 25 Jun 2026 01:03:30 GMT
• average basic shares outstanding of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:03:30 GMT
• non-operating income (total) of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:03:26 GMT
• operating income of sangamo therapeutics, inc. – otc:sgmoq TradingView Thu, 25 Jun 2026 01:00:02 GMT
• Inside Sangamo Therapeutics' bankruptcy: Dwindling choices, millions of dollars, more layoffs The Business Journals Wed, 24 Jun 2026 13:22:00 GMT
• sangamo files for bankruptcy as lilly and astellas target assets The Pharma Letter Wed, 24 Jun 2026 09:40:56 GMT
• eli lilly enters into agreement to acquire sangamo assets as stalking horse bidder in chapter 11 auction Paul, Weiss Wed, 24 Jun 2026 07:25:14 GMT
• sangamo bankruptcy puts gene therapy platforms in play, eli lilly and astellas circle Sahm Wed, 24 Jun 2026 07:22:36 GMT
• Biotech firm files for bankruptcy with $115M debt; Eli Lilly, Astellas bet on it anyway MassLive Wed, 24 Jun 2026 07:00:00 GMT
• A Gene-Therapy Pioneer Just Filed For Chapter 11 Bankruptcy—Now Eli Lilly Wants Its Tech inc.com Wed, 24 Jun 2026 07:00:00 GMT
• Sangamo holds a bankruptcy sale; VCs back a China-linked Beam competitor Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• gene editing pioneer sangamo files for chapter 11 bankruptcy; agrees to sell assets Genetic Engineering and Biotechnology News Wed, 24 Jun 2026 03:03:25 GMT
• lilly, astellas circle sangamo assets as biotech files for bankruptcy PharmaLive Tue, 23 Jun 2026 23:34:53 GMT
• sangamo bankruptcy puts gene therapy platforms in play, eli lilly and astellas circle Benzinga Tue, 23 Jun 2026 17:46:36 GMT
• Lilly, Astellas bid on Sangamo's assets after bankruptcy filing FirstWord Pharma Tue, 23 Jun 2026 17:34:34 GMT
• Sangamo’s three-decade run comes to a close as Lilly and Astellas eye assets Endpoints News Tue, 23 Jun 2026 15:57:00 GMT
• Sangamo Therapeutics files for bankruptcy after unique 30-year run The Business Journals Tue, 23 Jun 2026 13:39:00 GMT
• Form 8K Sangamo Therapeutics Inc For: 23 June By Investing.com Investing.com Canada Tue, 23 Jun 2026 12:55:43 GMT
• sangamo files for chapter 11, signs asset sale deals with lilly Investing.com South Africa Tue, 23 Jun 2026 12:53:18 GMT
• Sangamo Therapeutics Sets Stalking Horse Sales: $50M to Eli Lilly, Up to $50M to Astellas TradingView Tue, 23 Jun 2026 12:53:00 GMT
• Sangamo Therapeutics Files for Chapter 11 Bankruptcy Protection citybiz Tue, 23 Jun 2026 12:30:29 GMT
• sangamo therapeutics (sgmo) files for chapter 11 bankruptcy prot GuruFocus Tue, 23 Jun 2026 12:23:46 GMT
• Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers Fierce Biotech Tue, 23 Jun 2026 07:00:00 GMT
• UPDATE: Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy BioSpace Tue, 23 Jun 2026 07:00:00 GMT
• Gene Editing Pioneer Sangamo Files for Chapter 11 Bankruptcy; Agrees to Sell Assets Genetic Engineering and Biotechnology News Tue, 23 Jun 2026 07:00:00 GMT
• Sangamo falls after Chapter 11 bankruptcy filing; Eli Lilly and Astellas to acquire key assets Seeking Alpha Tue, 23 Jun 2026 07:00:00 GMT
• Sangamo Therapeutics(SGMO) Stock Options Chain | Quotes & News Moomoo Tue, 23 Jun 2026 07:00:00 GMT
• Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas The Manila Times Tue, 23 Jun 2026 07:00:00 GMT
• a gene therapy biotech firm has filed for chapter 11 bankruptcy WhatNow Tue, 23 Jun 2026 07:00:00 GMT
• sangamo therapeutics(sgmo) stock options chain | quotes & news Moomoo Fri, 19 Jun 2026 08:26:11 GMT
• sangamo therapeutics inc (sgmo) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 22:47:20 GMT
• Sangamo Therapeutics Inc (SGMO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 21:56:03 GMT
• sangamo therapeutics inc (sgmo) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:48:09 GMT
• sangamo therapeutics inc (sgmo) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 20:02:59 GMT
• sangamo therapeutics(sgmo) stock options chain | quotes & news Moomoo Fri, 12 Jun 2026 19:57:00 GMT
• Fabry Disease Market Unlocking New Revenue Opportunities and Strategic Expansion by 2034 – DelveInsight | Sanofi Genzyme, Sangamo ... Barchart.com Wed, 10 Jun 2026 07:00:00 GMT
• sangamo therapeutics(sgmo) stock options chain | quotes & news Moomoo Tue, 09 Jun 2026 15:38:24 GMT
• Sangamo Therapeutics explores strategic alternatives after burning through $1.6 billion The Business Journals Tue, 09 Jun 2026 07:00:00 GMT
• Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders Yahoo Finance Mon, 08 Jun 2026 07:00:00 GMT
• Biopharma bites: GSK's fibrosis deal, Sangamo's lifeline, and more from Sanofi, GNI FirstWord Pharma Mon, 08 Jun 2026 07:00:00 GMT
• Sangamo hires Raymond James to explore strategic alternatives By Investing.com Investing.com South Africa Mon, 08 Jun 2026 07:00:00 GMT
• sangamo therapeutics navigates nasdaq exit while advancing neurological pipeline AD HOC NEWS Thu, 04 Jun 2026 05:08:34 GMT
• sangamo therapeutics | 4: statement of changes in beneficial ownership of securities-officer davis gregory d Moomoo Thu, 28 May 2026 20:37:43 GMT
Sangamo Therapeutics, Inc(NASDAQ:SGMO) 
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a t...
Website: http://www.sangamo.com
Founded: 1995
Full Time Employees: 354
Sector: Healthcare
Industry: Biotechnology